Allogeneic

[키워드] acute respiratory syndrome administration adverse event Adverse reaction age Allogeneic analyzed baseline case sery cDCs Cell Cell therapy changes in clinical status compassionate-use control group coronavirus coronavirus disease Coronavirus-2 COVID-19 COVID-19 patient COVID-19 patients Critical Critically ill Critically ill patient Cytokine storm discharged Effectiveness Efficacy elevated female FIVE Follow-up hospital Hospitalization hyperinflammation improve clinical outcomes Infection initial intravenous Invasive mechanical ventilation leukocyte Lymphocyte count mechanically ventilated one patient overall mortality PaO Patient patients pro-inflammatory biomarker Randomized controlled trial required Respiratory Support SARS-CoV-2 severe disease therapeutic strategy therapy ventilatory support while WHO World Health Organization
[DOI] 10.1007/s00395-020-0795-1 PMC 바로가기 [Article Type] Original Contribution